Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-25-063629
Filing Date
2025-06-27
Accepted
2025-06-27 16:14:23
Documents
5
Period of Report
2025-06-27

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2519277-1_pre14a.htm PRE 14A 302495
2 GRAPHIC lg_carismatherapeutics-4c.jpg GRAPHIC 45021
3 GRAPHIC px_25carismaproxy1pg01-4c.jpg GRAPHIC 268025
4 GRAPHIC px_25carismaproxy1pg02-4c.jpg GRAPHIC 266894
5 GRAPHIC sg_stevenkelly-bw.jpg GRAPHIC 4735
  Complete submission text file 0001104659-25-063629.txt   1052786
Mailing Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36296 | Film No.: 251086446
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)